Why is spatial proteomics in the spotlight? Learn how mapping proteins in place is changing the way researchers study cells, diseases, and potential new drugs.
Positive results for breast cancer, funding for precision therapies for heart disease, strong results for Lilly’s oral GLP-1, and more led the news this week.
People with erythropoietic protoporphyria (EPP) must go to great lengths to avoid sun exposure. There have been no approved treatments that address the disease mechanism, but a new drug could change that.
Why is spatial proteomics in the spotlight? Learn how mapping proteins in place is changing the way researchers study cells, diseases, and potential new drugs.